Form 4: Astera Labs GC Awarded 5,893 RSUs Under Incentive Plan

Astera Labs' General Counsel and Secretary, Philip Mazzara, was granted 5,893 restricted stock units under the company's 2024 Stock Option and Incentive Plan.

Summary

• Philip Mazzara, General Counsel and Secretary of Astera Labs, Inc. (ALAB), acquired 5,893 restricted stock units (RSUs) on February 6, 2026.
• The RSUs were granted under the Astera Labs, Inc. 2024 Stock Option and Incentive Plan at a transaction price of $0.
• These RSUs represent a contingent right to receive one share of the Issuer's Common Stock for each RSU.
• The vesting schedule for these RSUs is 25% on February 15, 2027, with the remaining RSUs vesting in 12 equal quarterly installments thereafter.
• Vesting is contingent upon Mr. Mazzara's continuous service relationship with Astera Labs through each applicable vesting date.
• Following this transaction, Mr. Mazzara beneficially owns 142,933 shares of Common Stock, including these RSUs.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive event, reflecting standard executive compensation practices that align management incentives with long-term shareholder value, without indicating any immediate operational or financial changes.

Positives

• The grant of Restricted Stock Units (RSUs) to a key executive like the General Counsel aligns management's long-term interests with those of shareholders, as the value of the compensation is tied to the company's stock performance.
• The use of the 2024 Stock Option and Incentive Plan demonstrates a structured approach to executive compensation and retention.

Negatives

• The RSU grant represents potential future dilution for existing shareholders as the units vest and convert into common stock.

Risks

• The vesting of the RSUs is subject to the reporting person's continuous service relationship with Astera Labs, meaning the executive must remain employed to receive the shares.
• The ultimate value of the RSUs to the executive is dependent on the future market price of Astera Labs' common stock, introducing market risk.

Future Outlook

The vesting schedule for the RSUs, extending through quarterly installments after February 15, 2027, indicates a long-term retention strategy for the executive, aligning their future incentives with the company's sustained performance.

Industry Context

StockSavvy.ai notes that the grant of Restricted Stock Units (RSUs) is a prevalent form of executive compensation within the technology sector, particularly for growth-oriented companies like Astera Labs. This method is widely adopted to incentivize long-term performance and retain key talent by tying a significant portion of executive compensation to the company's stock price appreciation and continued service.

Comparison to Industry Standards

• The RSU grant structure, with a multi-year vesting schedule, is a standard practice in the technology industry for executive compensation, comparable to plans seen at companies like Nvidia, AMD, and Marvell Technology, which also utilize performance-based equity awards to align executive interests with shareholder value.
• The transaction price of $0 for RSUs at the time of grant is typical for such awards, as the value is realized upon vesting based on the prevailing market price of the common stock.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential for future dilution as RSUs vest, but also benefit from increased alignment of executive incentives with long-term stock performance.
• Employees (Executive): Philip Mazzara receives a significant equity award, enhancing his compensation and providing a strong incentive for continued service and performance.

Next Steps

• The first tranche of RSUs (25%) is scheduled to vest on February 15, 2027, subject to continuous service.
• Remaining RSUs will vest in 12 equal quarterly installments following the initial vesting date.

Key Dates

Recommendation

This Form 4 reports a routine RSU grant to a key executive, which is a standard compensation practice and does not introduce new material information that would warrant a change in investment recommendation. The event is neutral to slightly positive for long-term alignment but lacks immediate catalysts for significant price movement.

Keywords

Astera Labs, ALAB, Form 4, Restricted Stock Units, RSU, Executive Compensation, Insider Transaction, Stock Grant, Corporate Governance